Zepbound vs Wegovy 2026
Side-by-side comparison of the two FDA-approved branded GLP-1 weight-loss medications.
TL;DR Verdict
20.2% vs 13.7% in head-to-head SURMOUNT-5 trial — about 50% more weight loss
Slightly milder GI side-effect profile in some patients; longer FDA track record (approved 2021 vs 2023)
New oral Wegovy from $149/mo. Branded injectable Zepbound ~$1,498/mo; branded injectable Wegovy ~$1,839/mo
Head-to-Head At a Glance
| Factor | Zepbound | Wegovy | Winner |
|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide | — |
| Mechanism | Dual GIP + GLP-1 | GLP-1 only | Zepbound |
| Manufacturer | Eli Lilly | Novo Nordisk | — |
| FDA approval (weight loss) | 2023 | 2021 | Wegovy (longer track record) |
| Avg weight loss (trial) | 20.2% (SURMOUNT-1, 72 wk) | 14.9% (STEP-1, 68 wk) | Zepbound |
| Head-to-head (SURMOUNT-5) | 20.2% | 13.7% | Zepbound |
| Format(s) | Injectable only | Injectable + Oral Pill (new 2025) | Wegovy (more options) |
| Branded telehealth price | ~$1,498/mo | ~$1,839/mo (inj) / $149/mo (pill) | Wegovy Pill |
| Compounded available | Yes (compounded tirzepatide) | Yes (compounded semaglutide) | Tie |
Trial citations: SURMOUNT-1 (NEJM 2022), STEP-1 (NEJM 2021), SURMOUNT-5 (NEJM 2025). Pricing verified May 2026 from telehealth provider sites; branded GLP-1 pricing varies by pharmacy and insurance status.
Why Zepbound Often Produces More Weight Loss
Zepbound (tirzepatide) is the only dual GIP + GLP-1 receptor agonist on the market. Wegovy (semaglutide) targets only the GLP-1 receptor. The dual mechanism produces additional appetite suppression and metabolic effects beyond what a GLP-1-only agent achieves.
In SURMOUNT-5 — the only head-to-head trial of the two molecules — patients on tirzepatide lost 20.2% of body weight at 72 weeks vs 13.7% on semaglutide. That is roughly 50% more weight loss from the dual-agonist arm.
Source: SURMOUNT-5, NEJM 2025.
Side Effects Compared (Trial Data)
| Side Effect | Zepbound (SURMOUNT-1) | Wegovy (STEP-1) |
|---|---|---|
| Nausea | 31% | 44% |
| Diarrhea | 23% | 32% |
| Vomiting | 10% | 25% |
| Constipation | 17% | 24% |
| Discontinuation due to side effects | 6.2% | 7.0% |
Both medications carry FDA boxed warnings for thyroid C-cell tumors (based on rodent studies). Both are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a prescriber before starting.
Cost Comparison (Verified May 2026)
Branded — list price + cash-pay direct from manufacturers
Compounded — verified May 2026 telehealth pricing
All compounded provider pricing Gronk-verified May 5, 2026 directly from each provider’s public site. Insurance coverage for branded Zepbound and Wegovy varies. Use our cost calculator to estimate your 12-month spend at any provider.
The Insurance Loophole: Branded at $25/mo vs Compounded at $179/mo
Most patients comparing Zepbound and Wegovy don’t realize there are now three distinct cost paths, and the cheapest is often counterintuitive. Picking the right path matters more than picking the right drug — the cost gap between paths is wider than the cost gap between Zepbound and Wegovy.
Branded + Commercial Insurance + Savings Card
$25/mo
When commercial insurance covers Zepbound or Wegovy AND you stack the manufacturer’s savings card, out-of-pocket can drop as low as $25/mo. This is the cheapest path that exists — but it requires insurance coverage AND a current savings card eligibility check.
Eligibility: BMI ≥ 30 (or ≥ 27 + comorbidity), commercial insurance with coverage, savings card not previously exhausted.
Branded Cash-Pay (LillyDirect / Wegovy Pill)
$149–$699/mo
When insurance won’t cover, manufacturers now sell direct: LillyDirect cash-pay Zepbound vials start at $299 (starter dose) and scale to $399–$699 for maintenance doses. The Wegovy Pill (oral semaglutide) is $149/mo flat — the cheapest branded option that exists.
Eligibility: anyone with a valid prescription. No insurance required.
Compounded Cash-Pay (Telehealth)
$179–$399/mo
Compounded tirzepatide or semaglutide via 503A pharmacies under telehealth-prescribed plans. System Labs starts at $179/mo (lowest); Embody, Eden, Gala, Care Bare, and Direct Meds round out the $179–$399 range. NOT FDA-approved; tightening regulatory landscape post-April 2026.
Eligibility: anyone with a valid telehealth-prescribed compounded GLP-1.
Picking the right path — quick decision framework
- Path 1 (branded + insurance): Best if your commercial plan covers Zepbound or Wegovy and you haven’t exhausted the savings card. Always run an eligibility check first — your insurer knows in 2 minutes.
- Path 2 (LillyDirect / Wegovy Pill): Best if you want FDA-approved branded medication and don’t qualify for Path 1. The Wegovy Pill at $149/mo is genuinely the cheapest branded GLP-1 that has ever existed.
- Path 3 (compounded telehealth): Best if you’re comfortable with non-FDA-approved compounded versions, want to lock in entry-level pricing ($179/mo at System Labs), or want a needle-free format like Direct Meds sublingual or Embody’s GLP-1 gum. Note the post-April 2026 regulatory tightening.
Which One Should You Ask Your Doctor About?
Where to Get Zepbound or Wegovy
Verified branded-GLP-1 telehealth providers, May 2026.
Compare Branded GLP-1 Telehealth Providers
Pricing accurate as of May 2026. Click a provider to see current pricing and start a consultation. We may earn a commission — at no extra cost to you. See our affiliate disclosure.
| Provider | Monthly Price | Rating | Action |
|---|---|---|---|
Ivim HealthBest for Microdosing 360 wellness — branded + compounded + microdosing GLP-1Compounded Sema/Tirz/Liraglutide, microdosing GLP-1, Wegovy/Zepbound/Mounjaro/Ozempic/Saxenda, Wegovy Pill | From $75/mo + $74.99 program fee | ★★★★☆4.7 | View Best Offer |
Eden HealthBest Value Branded + compounded with intro pricingCompounded Sema + Tirz, branded GLP-1, NAD+ (5 formats), Sermorelin, hormone therapy | $149 intro / $229–$249 ongoing | ★★★★☆4.7 | View Best Offer |
OrderlyMeds Personalized GLP-1 + $3,700 value bundleCompounded Tirzepatide + Semaglutide, Wegovy, Zepbound | $149–$299 compounded, $1,498–$1,839 branded | ★★★★☆4.5 | View Best Offer |
GobyMeds Compounded GLP-1 with B12/NAD+ stack add-onsCompounded Sema + Tirz with B12/B6/NAD+/glycine combos, Wegovy, Zepbound, Sermorelin, NAD+ | From $99/mo (compounded sema) | ★★★★☆4.6 | View Best Offer |
Pricing and availability current as of May 2026. We earn a commission if you sign up through our links — at no additional cost to you. See our methodology for how we evaluate providers.
Still deciding between the two?
Take our 60-second quiz — we’ll match you to the right provider based on your medication preference, insurance, and budget.
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.
Related Guides
Continue your research with these related independent reviews.